Lentiviral Vectors for Cancer Immunotherapy and Clinical Applications

Por Liechtenstein, Therese, Perez-Janices, Noemi, Escors, David
Publicado em 2013

MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY

Por Liechtenstein, Therese, Dufait, Ines, Lanna, Alessio, Breckpot, Karine, Escors, David
Publicado em 2012

PD-L1/PD-1 Co-Stimulation, a Brake for T cell Activation and a T cell Differentiation Signal

Por Liechtenstein, Therese, Dufait, Ines, Bricogne, Christopher, Lanna, Alessio, Pen, Joeri, Breckpot, Karine, Escors, David
Publicado em 2012

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance

Por Dufait, Inès, Liechtenstein, Therese, Lanna, Alessio, Bricogne, Christopher, Laranga, Roberta, Padella, Antonella, Breckpot, Karine, Escors, David
Publicado em 2012

Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer

Por Dufait, Inès, Schwarze, Julia Katharina, Liechtenstein, Therese, Leonard, Wim, Jiang, Heng, Escors, David, De Ridder, Mark, Breckpot, Karine
Publicado no Oncotarget (2015)

Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity

Por Van der Jeught, Kevin, Joe, Patrick Tjok, Bialkowski, Lukasz, Heirman, Carlo, Daszkiewicz, Lidia, Liechtenstein, Therese, Escors, David, Thielemans, Kris, Breckpot, Karine
Publicado no Oncotarget (2014)

Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therape...

Por Liechtenstein, Therese, Perez-Janices, Noemi, Blanco-Luquin, Idoia, Goyvaerts, Cleo, Schwarze, Julia, Dufait, Ines, Lanna, Alessio, Ridder, Mark De, Guerrero-Setas, David, Breckpot, Karine, Escors, David
Publicado no Oncoimmunology (2014)

Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?

Por Escors, David, Liechtenstein, Therese, Perez-Janices, Noemi, Schwarze, Julia, Dufait, Ines, Goyvaerts, Cleo, Lanna, Alessio, Arce, Frederick, Blanco-Luquin, Idoia, Kochan, Grazyna, Guerrero-Setas, David, Breckpot, Karine
Publicado em 2013

A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice

Por Liechtenstein, Therese, Perez-Janices, Noemi, Gato, Maria, Caliendo, Fabio, Kochan, Grazyna, Blanco-Luquin, Idoia, Van der Jeught, Kevin, Arce, Frederick, Guerrero-Setas, David, Fernandez-Irigoyen, Joaquin, Santamaria, Enrique, Breckpot, Karine, Escors, David
Publicado em 2014

A core of kinase-regulated interactomes defines the neoplastic MDSC lineage

Por Gato-Cañas, Maria, de Morentin, Xabier Martinez, Blanco-Luquin, Idoia, Fernandez-Irigoyen, Joaquin, Zudaire, Isabel, Liechtenstein, Therese, Arasanz, Hugo, Lozano, Teresa, Casares, Noelia, Chaikuad, Apirat, Knapp, Stefan, Guerrero-Setas, David, Escors, David, Kochan, Grazyna, Santamaría, Enrique
Publicado no Oncotarget (2015)

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis

Por Perez-Janices, Noemi, Blanco-Luquin, Idoia, Torrea, Natalia, Liechtenstein, Therese, Escors, David, Cordoba, Alicia, Vicente-Garcia, Francisco, Jauregui, Isabel, De La Cruz, Susana, Illarramendi, José Juan, Coca, Valle, Berdasco, Maria, Kochan, Grazyna, Ibañez, Berta, Lera, José Miguel, Guerrero-Setas, David
Publicado no Oncotarget (2015)